©
Gerd Altmann - Pixabay
Brain damage through injury or disease is devastating for the patient, their families and society. Furthermore, the global economic consequences are known to be expanding exponentially; Alzheimer’s Disease alone is projected to affect 92 million people by 2050 when the costs associated with dementia could reach $1.1 trillion a year. So far, existing pharmaceutical and biotherapeutic treatments have been insufficient and clinical trials have repeatedly failed.
Read the full article (DPAG website)